ArticleCells2024

FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist.

Chih-Chieh Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.